Breakthrough blood test could detect cancer killing more than 12,000 each year

Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

New blood test could start national screening programme for 55,000 annual cancer patients

The University of Cambridge is developing a blood test that could detect a common cancer that kills 12,000 people each year.

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...

Predicting prostate cancer recurrence through power of AI

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
News-Medical.Net on MSN

Novel liquid biopsy technology could advance cancer diagnostics and monitoring

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...